When a collective outcome triggers a rare individual event: A mode of metastatic process in a cell population

Mathematical Population Studies

Volumn 17, Issue 3, 2010, Pages 136-165

  Malo, Michel ^a   Cartier Michaud, Amandine ^a   Fabre Guillevin, Elisabeth ^a,b   Hutzler, Guillaume ^a   Delaplace, Franck ^a   Barlovatz Meimon, Georgia ^a,c   Lesne, Annick ^d,e  

^a UNIVERSITY OF EVRY   (France)

^b HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^c UNIVERSITÉ PARIS EST CRÉTEIL   (France)

^d INSTITUT DES HAUTES ÉTUDES SCIENTIFIQUES   (France)

^e UNIVERSITÉ PIERRE ET MARIE CURIE   (France)

Author keywords

Agent based simulation; Cell population; Metastastic escape; Multilevel model; Multistability; Reaction diffusion

Indexed keywords

CANCER; CELL ORGANELLE; CELLULAR AUTOMATON; COMPUTER SIMULATION; CONCENTRATION (COMPOSITION); DIFFUSION; HETEROGENEITY; POPULATION SIZE; PROTEIN; STABILIZATION; THRESHOLD; TUMOR;

EID: 77955337812     PISSN: 08898480     EISSN: 1547724X     Source Type: Journal    
DOI: 10.1080/08898480.2010.490996     Document Type: Article

References (32)

1. Albini, A. (2008). Tumor microenvironment, a dangerous society leading to cancer metastasis. From mechanisms to therapy and prevention. Cancer and Metastasis Reviews, 27: 3-4.
2. Albini, A., Mirisola, V., and Pfeffer, U. (2008). Metastasis signatures: Gene regulating tumor-microenvironment interactions predict metastatic behavior. Cancer and Metastasis Reviews, 27: 75-83.
3. Berx, G., Raspé, E., Christofori, G., et al.(2007).Pre-EM Tingmetastasis? Recapitulation of morphogenetic processes in cancer. Clinical and Experimental Metastasis, 24: 587-597.
4. Bidard, F.C., Pierga, J.Y., Vincent-Salomon, A., and Poupon, M.F. (2008). A class action against the microenvironment: Do cancer cells cooperate in metastasis? Cancer and Metastasis Reviews, 27: 5-10.
5. Biermann, J.C., Holzscheiter, L., Kotzsch, M., et al. (2008). Quantitative RT-PCR assays for the determination of urokinase-type plasminogen activator and plasminogen activator inhibitor type 1 mRNA in primary tumor tissue of breast cancer patients: Comparison to antigen quantification by ELISA. International Journal of Molecular Medicine, 21: 251-259.
6. Castelló, R., Landete, J.M., España, F., et al. (2007). Expression of plasminogen activator inhibitors type 1 and type 3 and urokinase plasminogen activator protein and mRNA in breast cancer. Thrombosis Research, 120: 753-762.
7. Chazaud, B., Bonavaud, S., Plonquet, A., et al. (2000). Involvement of the [uPAR:uPA:PAI-1:LRP] complex in human myogenic cell motility. Experimental Cell Research, 258: 237-244.
8. Chazaud, B., Ricoux, R., Christov, C., et al. (2002). Promigratory effect of plasminogen activator inhibitor-1 on invasive breast cancer cell populations. American Journal of Pathology, 160: 237-246.
9. Czekay, R.P. and Loskutoff, D.J. (2004). Unexpected role of plasminogen activator inhibitor 1 in cell adhesion and detachment. Experimental Biology and Medecine, (Maywood), 229: 1090-1096.
10. Friedl, P. (2004). Pre-specification and plasticity: Shifting mechanisms of cell migration. Current Opinions in Cell Biology, 16: 14-23.
11. Friedl, P. and Wolf, K. (2003). Tumour-cell invasion and migration: Diversity and escape mechanisms. Nature Reviews Cancer, 3: 362-374.
12. Gavert, N. and Ben-Ze'ev, A. (2008). Epithelial-mesenchymal transition and the invasive potential of tumors. Trends in Molecular Medecine, 14: 199-209.
13. Gerstung, M. and Beerenwinkel, N. (2010/this issue). Waiting time models of cancer progression. Mathematical Population Studies, 17: 115-135.
14. Hoehme, S. and Drasdo, D. (2010/this issue). Biomechanical and nutrient controls in the growth of mammalian cell populations. Mathematical Population Studies, 17: 166-187.
15. Jänicke, F., Prechtl, A., Thomssen, C., et al. (2001). Randomized adjuvant chemotherapy trial in high-risk, lymph node-negative breast cancer patients identified by urokinase-type plasminogen activator and plasminogen activator inhibitor type 1. Journal of the National Cancer Institute, 93: 913-920.
16. Landau, L.D. and Lifshitz, E.M. (1959). Fluid Mechanics. London: Pergamon Press.
17. Lesne, A. (2007). Discrete vs continuous controversy in physics. Mathematical Structure in Computer Science, 17: 185-223.
18. Lesne, A. (2008). Robustness: Confronting lessons from physics and biology. Biological Reviews, 83: 509-532.
19. Look, M.P., van Putten, W.L.J., Duffy, M.J., et al. (2002). Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients. Journal of the National Cancer Institute, 94: 116-128.
20. Malo, M., Charrière-Bertrand, C., Chettaoui, C., et al. (2006). The PAI-1 swing: Microenvironment and cancer cell migration. Comptes Rendus Biologie, 329: 919-927.
21. McCarthy, N. (2009). Metastasis: Moved to act. Nature Reviews Cancer, 9: 3.
22. Pedersen, T.X., Pennington, C.J., Almholt, K., et al. (2005). Extracellular protease mRNAs are predominantly expressed in the stromal areas of microdissected mouse breast carcinomas. Carcinogenesis, 26: 1233-1240.
23. Ruelle, D. (1989). Elements of Differentiable Dynamics and Bifurcation Theory. New York: Academic Press.
24. Sanz-Moreno, V., Gadea, G., Ahn, J., et al. (2008). Rac activation and inactivation control plasticity of tumor cell movement. Cell, 135: 510-523.
25. Taylor, J., Hickson, J., and Lotan, T. (2008). Using metastasis suppressor proteins to dissect interactions among cancer cells and their microenvironment. Cancer and Metastasis Reviews, 27: 67-73.
26. Thiery, J.P. (2002). Epithelial-mesenchymal transitions in tumor progression. Nature Reviews Cancer, 2: 442-454.
27. Thom, R. (1975). Structural Stability and Morphogenesis. Reading, MA: Benjamin Addison Wesley.
28. Vincan, E., Brabletz, T., Faux, M.C., and Ramsay, R.G. (2007). A human three-dimensional cell line model allows the study of dynamic and reversible epithelial-mesenchymal and mesenchymal-epithelial transition that underpins colorectal carcinogenesis. Cells Tissues Organs, 185: 20-28.
29. Whiteside, T.L. (2008). The tumor microenvironment and its role in promoting tumor growth. Oncogene, 27: 5904-5912.
30. Wilkins-Port, C.E. and Higgins, P.J. (2007). Regulation of extracellular matrix remodelling following transforming growth factor-beta1/epidermal growth factorstimulated epithelial-mesenchymal transition in human premalignant keratinocytes. Cells Tissues Organs, 185: 116-122.
31. Wilkins-Port, C.E., Higgins, C.E., Freytag, J., et al. (2007). PAI-1 is a critical upstream regulator of the TGF-β1/EGF-induced invasive phenotype in mutant p53 human cutaneous squamous cell carcinoma. Journal of Biomedicine and Biotechnology, 85208. doi: 10.1155/2007/85208
32. Witz, I.P. (2008). Tumor-microenvironment interactions: Dangerous liaisons. Advances in Cancer Research, 100: 203-229.